✦ LIBER ✦

Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity

✍ Scribed by Xianglin L. Du; Wenyaw Chan; Sharon Giordano; Jane M. Geraci; George L. Delclos; Keith Burau; Shenying Fang

Book ID: 102110004
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 110 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21271

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Large Age, Socioeconomic and Hospital-De

Large Age, Socioeconomic and Hospital-Dependent Variation in Administration of Chemotherapy for Stage IV NSCLC

✍ Aarts⁎, M.; van den Borne, B.; Biesma, B.; Kloover, J.; Aerts, J.; Lemmens, V. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 145 KB

In older adults with breast and colorect

In older adults with breast and colorectal cancer, multimorbidity, but not age, is associated with hospital admissions for chemotherapy-related adverse events

✍ Koroukian, S.M.; Bakaki, P.M.; Htoo, P.T.; Schluchter, M.; Owusu, C.; Berger, N. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 66 KB

Feasibility and toxicity of high-dose ch

Feasibility and toxicity of high-dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast carcinoma

✍ Drakos, P; Nagler, A; Or, R; Naparstek, E; Kapelushnik, J; Slavin, S 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Decreased cardiac toxicity of doxorubici

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

✍ G. N. Hortobagyi; D. Frye; A. U. Buzdar; M. S. Ewer; G. Fraschini; V. Hug; F. Am 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB

Two hundred and seventy-four consecutive patients with measurable metastatic breast cancer, without prior exposure to cytotoxic agents were treated with tamoxifen, 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC). The initial 133 patients received doxorubicin by bolus IV administration and fo

Augmentation of anticancer effect with a

Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinoma

✍ Shinzaburo Noguchi; Keisuke Miyauchi; Yukio Nishizawa; Yo Sasaki; Shingi Imaoka; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

57LBA Aprepitant (APR) for the preventio

57LBA Aprepitant (APR) for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) in breast and non-breast cancers

✍ R. Gralla; B. Rapoport; C. Brown; J.C. Street; J.S. Hardwick; A.D. Carides 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB